| Mr Brian T Daniel, CRNA | |
|
803 Poplar St, Murray, KY 42071-2432 | |
| (270) 762-1100 | |
| Not Available |
| Full Name | Mr Brian T Daniel |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 803 Poplar St, Murray, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730460361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 34124 (Tennessee) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 3007135 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Murray Anesthetists Group, Pllc | 6709057854 | 15 |
| Baptist Memorial Hospital-huntingdon | 4082509757 | 12 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Covidien plc and Somanetics Corporation today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash acquired.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Pseudogenes, a sub-class of long non-coding RNA (lncRNA) that developed from the genome's 20,000 protein-coding genes but lost the ability to produce proteins, have long been considered nothing more than genomic "junk." Yet the retention of these 20,000 mysterious remnants during evolution has suggested that they may in fact possess biological functions and contribute to the development of disease.
› Verified 1 days ago
| Entity Name | Trigg County Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20031205000118 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Covidien plc and Somanetics Corporation today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash acquired.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Pseudogenes, a sub-class of long non-coding RNA (lncRNA) that developed from the genome's 20,000 protein-coding genes but lost the ability to produce proteins, have long been considered nothing more than genomic "junk." Yet the retention of these 20,000 mysterious remnants during evolution has suggested that they may in fact possess biological functions and contribute to the development of disease.
› Verified 1 days ago
| Entity Name | Murray Anesthetists Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164701447 PECOS PAC ID: 6709057854 Enrollment ID: O20110921000110 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Covidien plc and Somanetics Corporation today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash acquired.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Pseudogenes, a sub-class of long non-coding RNA (lncRNA) that developed from the genome's 20,000 protein-coding genes but lost the ability to produce proteins, have long been considered nothing more than genomic "junk." Yet the retention of these 20,000 mysterious remnants during evolution has suggested that they may in fact possess biological functions and contribute to the development of disease.
› Verified 1 days ago
| Entity Name | Apex Anesthesia Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902373772 PECOS PAC ID: 3476891656 Enrollment ID: O20190213001951 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Covidien plc and Somanetics Corporation today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash acquired.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Pseudogenes, a sub-class of long non-coding RNA (lncRNA) that developed from the genome's 20,000 protein-coding genes but lost the ability to produce proteins, have long been considered nothing more than genomic "junk." Yet the retention of these 20,000 mysterious remnants during evolution has suggested that they may in fact possess biological functions and contribute to the development of disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Brian T Daniel, CRNA 965 Ridge Lake Blvd, Memphis, TN 38120-9401 Ph: (901) 227-4692 | Mr Brian T Daniel, CRNA 803 Poplar St, Murray, KY 42071-2432 Ph: (270) 762-1100 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Covidien plc and Somanetics Corporation today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash acquired.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Pseudogenes, a sub-class of long non-coding RNA (lncRNA) that developed from the genome's 20,000 protein-coding genes but lost the ability to produce proteins, have long been considered nothing more than genomic "junk." Yet the retention of these 20,000 mysterious remnants during evolution has suggested that they may in fact possess biological functions and contribute to the development of disease.
› Verified 1 days ago
Edward S Parrish Iii, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 803 Poplar St, Murray, KY 42071 Phone: 270-762-1100 | |
Mr. Adam Shane David, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 859-948-8389 | |
Margaret L. Daniel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 831-431-3243 | |
Ashley Jane Young, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Suite 400, Murray, KY 42071 Phone: 270-293-9637 | |
Jennifer A Green, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 270-748-6851 | |
Maria D Jennings, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 270-227-6405 | |
Amy Lockwood, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 270-705-9065 |